2025-02-22T16:58:40-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: Query fl=%2A&wt=json&json.nl=arrarr&q=id%3A%22irk-123456789-137603%22&qt=morelikethis&rows=5
2025-02-22T16:58:40-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: => GET http://localhost:8983/solr/biblio/select?fl=%2A&wt=json&json.nl=arrarr&q=id%3A%22irk-123456789-137603%22&qt=morelikethis&rows=5
2025-02-22T16:58:40-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: <= 200 OK
2025-02-22T16:58:40-05:00 DEBUG: Deserialized SOLR response
Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma
Aim: To investigate anticancer and immunologic effects of chicken embryonic proteins (CEP) in mice bearing Ehrlich solid carcinoma. Materials and Methods: The study was carried out on male Balb/c mice bearing Ehrlich solid carcinoma. The immunizations were performed after the tumor transplantation....
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2017
|
Series: | Experimental Oncology |
Subjects: | |
Online Access: | http://dspace.nbuv.gov.ua/handle/123456789/137603 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
irk-123456789-137603 |
---|---|
record_format |
dspace |
spelling |
irk-123456789-1376032018-06-18T03:09:50Z Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma Symchych, T.V. Fedosova, N.I. Karaman, O.M. Yevstratieva, L.M. Voyeykova, I.M. Potebnia, H.P. Original contributions Aim: To investigate anticancer and immunologic effects of chicken embryonic proteins (CEP) in mice bearing Ehrlich solid carcinoma. Materials and Methods: The study was carried out on male Balb/c mice bearing Ehrlich solid carcinoma. The immunizations were performed after the tumor transplantation. The immune status was assessed on days 7, 14, 21 and 28 after the tumor challenge. Cytotoxic activity (CAT) of macrophages (Mph), natural killer cells (NK), cytotoxic T-lymphocytes (CTL) and blood serum, as well as the influence of the blood serum on immune cells activity was checked in MTT-assay; Mph’s cytochemical activity was tested in NBT-assay; Ehrlich antigen-specific or CEP-specific antibodies were detected in ELISA-assay; medium size circulating immune complexes (CIC) were detected in reaction of 4.5% polyethylene glycol precipitation. Results: The immunization resulted in tumor growth suppression and significant 25.64% prolongation of the survival time. In both control and immunized mice with transplanted tumors antibodies specific to Ehrlich carcinoma antigens and to CEP were detected, but antibody response was more balanced in the treatment group. In the treatment group both cytochemical and CAT of Mph was moderately activated and well preserved until late stages of tumor development; CAT of NK and CTL remained in the range of the intact mice until day 28 after the tumor transplantation. The immunized mice were well protected from accumulation of CIC and suppressive activity of autologous blood serum. Conclusion: Collectively, our data indicate that CEP can elicit immunomodulating and immunoprotecting effects sufficient to provide tumor growth inhibition. The further elaboration of a xenogeneic anticancer vaccine based on CEP is warranted. 2017 Article Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma / T.V. Symchych, N.I. Fedosova, O.M. Karaman, L.M. Yevstratieva, I.M. Voyeykova, H.P. Potebnia // Experimental Oncology. — 2017 — Т. 39, № 1. — С. 42-48. — Бібліогр.: 27 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/137603 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
collection |
DSpace DC |
language |
English |
topic |
Original contributions Original contributions |
spellingShingle |
Original contributions Original contributions Symchych, T.V. Fedosova, N.I. Karaman, O.M. Yevstratieva, L.M. Voyeykova, I.M. Potebnia, H.P. Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma Experimental Oncology |
description |
Aim: To investigate anticancer and immunologic effects of chicken embryonic proteins (CEP) in mice bearing Ehrlich solid carcinoma. Materials and Methods: The study was carried out on male Balb/c mice bearing Ehrlich solid carcinoma. The immunizations were performed after the tumor transplantation. The immune status was assessed on days 7, 14, 21 and 28 after the tumor challenge. Cytotoxic activity (CAT) of macrophages (Mph), natural killer cells (NK), cytotoxic T-lymphocytes (CTL) and blood serum, as well as the influence of the blood serum on immune cells activity was checked in MTT-assay; Mph’s cytochemical activity was tested in NBT-assay; Ehrlich antigen-specific or CEP-specific antibodies were detected in ELISA-assay; medium size circulating immune complexes (CIC) were detected in reaction of 4.5% polyethylene glycol precipitation. Results: The immunization resulted in tumor growth suppression and significant 25.64% prolongation of the survival time. In both control and immunized mice with transplanted tumors antibodies specific to Ehrlich carcinoma antigens and to CEP were detected, but antibody response was more balanced in the treatment group. In the treatment group both cytochemical and CAT of Mph was moderately activated and well preserved until late stages of tumor development; CAT of NK and CTL remained in the range of the intact mice until day 28 after the tumor transplantation. The immunized mice were well protected from accumulation of CIC and suppressive activity of autologous blood serum. Conclusion: Collectively, our data indicate that CEP can elicit immunomodulating and immunoprotecting effects sufficient to provide tumor growth inhibition. The further elaboration of a xenogeneic anticancer vaccine based on CEP is warranted. |
format |
Article |
author |
Symchych, T.V. Fedosova, N.I. Karaman, O.M. Yevstratieva, L.M. Voyeykova, I.M. Potebnia, H.P. |
author_facet |
Symchych, T.V. Fedosova, N.I. Karaman, O.M. Yevstratieva, L.M. Voyeykova, I.M. Potebnia, H.P. |
author_sort |
Symchych, T.V. |
title |
Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma |
title_short |
Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma |
title_full |
Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma |
title_fullStr |
Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma |
title_full_unstemmed |
Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma |
title_sort |
anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma |
publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
publishDate |
2017 |
topic_facet |
Original contributions |
url |
http://dspace.nbuv.gov.ua/handle/123456789/137603 |
citation_txt |
Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma / T.V. Symchych, N.I. Fedosova, O.M. Karaman, L.M. Yevstratieva, I.M. Voyeykova, H.P. Potebnia // Experimental Oncology. — 2017 — Т. 39, № 1. — С. 42-48. — Бібліогр.: 27 назв. — англ. |
series |
Experimental Oncology |
work_keys_str_mv |
AT symchychtv anticancereffectandimmunologicresponsetoxenogeneicembryonicproteinsinmicebearingehrlichsolidcarcinoma AT fedosovani anticancereffectandimmunologicresponsetoxenogeneicembryonicproteinsinmicebearingehrlichsolidcarcinoma AT karamanom anticancereffectandimmunologicresponsetoxenogeneicembryonicproteinsinmicebearingehrlichsolidcarcinoma AT yevstratievalm anticancereffectandimmunologicresponsetoxenogeneicembryonicproteinsinmicebearingehrlichsolidcarcinoma AT voyeykovaim anticancereffectandimmunologicresponsetoxenogeneicembryonicproteinsinmicebearingehrlichsolidcarcinoma AT potebniahp anticancereffectandimmunologicresponsetoxenogeneicembryonicproteinsinmicebearingehrlichsolidcarcinoma |
first_indexed |
2023-10-18T21:16:09Z |
last_indexed |
2023-10-18T21:16:09Z |
_version_ |
1796152373432811520 |